Precigen, Inc.
PGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 241.4% | -36.2% | 12.7% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 64.6% | -81.7% | 18% | 1.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -4,950% | -3,180.7% | -3,991.3% | -1,609.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,008.4% | -3,112.4% | -4,038.3% | -1,657.7% |
| EPS Diluted | -1.1 | -0.09 | -0.18 | -0.067 |
| % Growth | -1,123.6% | 50.1% | -167.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |